A recent study reveals that people who come off blockbuster slimming jabs like Wegovy and Mounjaro tend to recover shed pounds at a significantly accelerated pace than those who end conventional diet and exercise programs.
Published data in a prominent health publication points out that while obese people can lose a large proportion of their total mass while on the medication, the mass comes back at an estimated rate of nearly a kilo each month once they quit.
"People purchasing such drugs must be aware of the danger of rapid rebound weight gain when the medication concludes," stated expert Dr. Susan Jebb.
Such speed of regain suggests a return to original weight in about a year and a half.
Analyzing Approaches
The research, which reviewed 37 of trials involving over 9,000 of patients, contrasted the effects of GLP-1 agonists with other pills.
Researchers point out that people who shed pounds through dieting typically experience a less rapid weight regain—approximately 0.1 kg a month—after stopping.
Explaining the Rapid Rebound
Nutrition scientists propose the way of the jabs accounts for the amplified rebound.
GLP-1 drugs copy a natural hormone called GLP-1, which helps regulate appetite.
"Artificially providing the hormone levels several times higher than the body's typical production might result in the body to produce less of its endogenous hormone, and could diminish sensitivity to its effects," said Dr. Adam Collins, a dietetics specialist.
"Stopping of this hormone supplement leads to appetite is no longer kept in check, making excessive eating a significant risk."
An Ongoing Condition?
Medical guidelines advise the jabs for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
Many experts contend that, given the likelihood of relapse, the treatment should be considered long-term.
This perspective is echoed by pharmaceutical companies, who note that the findings "emphasize the persistent character of obesity," similar to managing conditions like hypertension.
Patient Testimonies
People who have discontinued the jabs report a sudden return of hunger.
"It felt as if a switch activating and you're instantly starving," recalled a patient.
This difficulty is worsened if users have not developed sustainable dietary or behavioural changes during treatment.
Growing Adoption
Survey data show that millions of adults in the UK have used these injections in the last 12 months, with interest remaining high.
- Use is more common among females compared to men.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than the NHS.
In conclusion, experts emphasize that while these medications are effective agents for shedding pounds, they are not a permanent cure and lasting health benefits hinges on combined behavioural management.
